VEGFA and ovarian carcinoma: Finally, rAAV vectors encoding monoclonal antibodies such as bevacizumab to target VEGF and prevent angiogenesis have also been encoded in AAV vectors and reduce tumor burden in a xenograft mouse model of ovarian cancer [31].